Payson Norman 4
4 · Progyny, Inc. · Filed May 26, 2023
Insider Transaction Report
Form 4
Progyny, Inc.PGNY
Payson Norman
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-24+17,670→ 17,670 totalExercise: $38.24Exp: 2033-05-23→ Common Stock (17,670 underlying) - Award
Common Stock
2023-05-24+4,385→ 7,865 total
Holdings
- 281,098(indirect: See footnote)
Common Stock
- 122,493(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date.
- [F2]The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
- [F3]The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
- [F4]The shares subject to the Option shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date.